The In-Home, Multi-Specialty Disruptor was Ranked No. 2 Throughout the Healthcare and Medical Industry and No. 1 in the State of Tennessee
NASHVILLE, Tenn. – Monogram Health, the leading multi-specialty provider of in-home, evidence-based care for patients suffering from multiple chronic conditions, revealed its rank as the 7th Fastest Growing Company in the United States by Inc. Magazine. This 2025 distinction marks the second consecutive year that Monogram Health has ranked amongst the top 7 of the fastest growing companies in America (previously listed No. 3 in 2024).
Companies on the 2025 Inc. 5000 are ranked according to their percentage of revenue growth from 2021 to 2024. Among the top 500 companies on this year’s list, the median three-year revenue growth rate reached 1,552%, whereas Monogram’s three-year revenue growth rate was at 14,131%. Upon a comprehensive analysis of the ranking, Monogram Health ranked No. 2 fastest growing company across the healthcare and medical industry and No. 1 in the state of Tennessee.
“Monogram Health is on a mission to revolutionize the way care is delivered to polychronic patients throughout the United States. Being ranked among the top 7 for two consecutive years is a true testament to the profitable growth, and scale of Monogram Health to date, and the immense potential still on the horizon,” said Michael Uchrin, Co-Founder and CEO of Monogram Health. “Our model continues to be both efficient and effective in improving patient health outcomes, while also reducing unnecessary hospitalizations and lowering costs for all parties involved. Our personalized, in-home, multispecialty approach is unique and our positive impact on patients, providers, payers, and the healthcare industry alike is profound.”
Founded in 2019, Monogram Health has rapidly emerged as the leader in multi-specialty, in-home, value-based care through a disciplined and aggressive growth strategy, focused on building and expanding strategic partnerships with the nation’s largest health plans, integrated health systems, and risk-based primary care platforms. From $4.9 million in 2020, Monogram’s revenue surged to more than $21 million and $310 million in 2021 and 2022, respectively, before jumping to more than $2 billion in 2023 and more than $3 billion in 2024. Monogram Health continues to strategically scale, employing around 1,500 people across 36 states with anticipated revenues of $5 billion in 2025.
“Earning a spot on this year’s list speaks volumes about a company’s tenacity and clarity of vision,” says Mike Hofman, Editor-in-Chief of Inc. “These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn’t just weather the storm—they grew through it.”
To view the full list of 2025 Inc. 5000 honorees, visit:www.inc.com/inc5000.
To learn more about the “Monogram Health Difference,” visit:https://www.monogramhealth.com/the-monogram-difference/.
